Clinical Trial Update: Safety & Efficacy of Dual Therapy With Raltegravir/Lamivudine [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the safety and efficacy of dual therapy with raltegravir and lamivudine in AIDS. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome

Drugs mentioned

• Epivir (Lamivudine)
• Isentress (Raltegravir)

Snippet

Sponsor: Juan A. Arnaiz | Conditions: AIDS | Phase 3 | Status: COMPLETED | Results posted: 2025-07-20